Deferiprone(CAS: 30652-11-0)

Deferiprone is a crystalline compound with a molecular weight of approximately 316.3 g/mol. It is poorly soluble in water but soluble in organic solvents. Chemically, it is reactive towards bases and oxidizing agents. It is mainly used in the treatment of iron overload and has limited solubility, making it challenging to formulate for oral administration without solubilizing agents.

Deferiprone is typically synthesized through a multi-step process involving condensation reactions, amidation, and ring formation. Common methods include the use of 1,2-diaminopropane and 2,2'-iminodiethanoyl chloride as starting materials. The synthesis involves the formation of key intermediates and final coupling reactions to yield the target compound with good yields and selectivity.

Deferiprone is primarily used in the pharmaceutical industry for the treatment of iron overload disorders. It is also relevant in academic research for studying iron metabolism and its effects on various cell functions. Although not widely used in other industries, its applications in biotechnology and potential use in drug screening platforms make it of interest in these sectors.

When handling Deferiprone, it is important to wear appropriate personal protective equipment (PPE) such as gloves and safety goggles. Work should be conducted in a well-ventilated area or a fume hood. Spills should be cleaned up carefully, and proper disposal methods should be followed. Always refer to the Safety Data Sheet (SDS) for detailed information on handling and storage to ensure safe laboratory practices.